Iododoxorubicin hydrochloride is an anthracycline anticancer agent and analog of doxorubicin, mainly investigated for its role in chemotherapy. It is grouped under the following drug class(es): Anthracyclines and Topoisomerase inhibitors. The directory classifies it as a clinical API with a semi-synthetic source/manufacturing origin. Other names for this substance include 31I1O326SE, UNII-31I1O326SE and NSC 378901. Its PubChem CID is 13189887.
Iododoxorubicin hydrochloride
| CAS No | 83943-83-3 |
|---|---|
| Molecular Formula | C27H29ClINO10 |
| Molecular Weight | 689.9 g/mol |
| Synonyms | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Iododoxorubicin hydrochloride is an anthracycline anticancer agent and analog of doxorubicin, mainly investigated for its role in chemotherapy. It is grouped under the following drug class(es): Anthracyclines and Topoisomerase inhibitors.
The listed CAS number is 83943-83-3.
The listed molecular formula is C27H29ClINO10.
The listed molecular weight is 689.9 g/mol.
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride.
The source lists 31I1O326SE, UNII-31I1O326SE and NSC 378901.